Vol 25, No 6 (2020)
Original research articles
Published online: 2020-11-01

open access

Page views 174
Article views/downloads 245
Get Citation

Connect on Social Media

Connect on Social Media

Survival and consolidative radiotherapy in patients living with HIV and treated for diffuse large B-cell lymphoma

Lucas Coelho Casimiro1, Geovanne Pedro Mauro23, Carolina Trindade Medici4, Eduardo Weltman53
DOI: 10.1016/j.rpor.2020.09.004
Rep Pract Oncol Radiother 2020;25(6):956-960.

Abstract

Objectives

Current guidelines tend to treat HIV positive (HIV+) patients as their seronegative counterparts with diffuse large B-cell lymphoma (DLBCL) but little is known about their radiotherapy responses differences.

Patients and Methods

A retrospective cohort of all consecutive HIV+ DBCL patients treated with chemotherapy between 2004 and 2018 was assessed. All patients had biopsy-proven lymphomas. They were included if the proposed radical treatment was done without progression or death during chemotherapy and had at least 6 months of follow-up or were followed until death.

Results

Fifty-three (53) patients were selected, with a median age at diagnosis of 41.39 years (20–65 years). Median follow-up of 35.16 months (1.4–178.7 months). Male patients accounted for 54.7% and most had a good performance in the ECOG scale at diagnoses (81.1% are ECOG 0−1). Median overall survival was not reached. Mean OS was 41.5 months with 16 deaths. Age had an impact on OS, with patients older than 60 years at more risk (p = 0.044), as did longtime use of HAART, with those that started antiretroviral therapy within the diagnose of the lymphoma at greatest risk (p = 0.044). RT did not have an impact on OS (p = 0.384) or PFS (p = 0.420), although survival curves show better OS in the radiotherapy group. Toxicities were rare, since none of the patients had grade 3 or superior toxicity.

Conclusion

RT did not impact survival or progression in our limited sample, but a longer OS may occur after the first-year post RT. RT should be tested in prospective data in the HIV+ population with DLBCL.

Article available in PDF format

View PDF Download PDF file



Reports of Practical Oncology and Radiotherapy